文献速递腹部泌尿生殖技术与安全CT

人工智能迭代重建低剂量术前CT诊断卵巢肿瘤腹膜侵犯、淋巴结及肝转移的价值

The utility of low-dose pre-operative CT of ovarian tumor with artificial intelligence iterative reconstruction for diagnosing peritoneal invasion, lymph node and hepatic metastasis.
PubMed 文献 · Abdom Radiol (NY) · 2025-05-13

本研究前瞻性纳入88例病理确诊卵巢肿瘤患者,比较常规剂量门静脉期CT联合混合迭代重建(HIR)与低剂量CT联合人工智能迭代重建(AIIR)的诊断效能。低剂量AIIR对腹膜侵犯、淋巴结转移和肝转移的诊断准确性与常规剂量HIR相似,有效剂量降低79.8%,表明AIIR可实现最高80%的剂量缩减且诊断安全。

要点

  • 低剂量AIIR与常规剂量HIR诊断腹膜侵犯的AUC分别为0.961和0.960,无显著差异(p=0.734)。
  • 低剂量AIIR诊断淋巴结转移的AUC为0.711,常规剂量HIR为0.715,两者无显著差异(p=0.355)。
  • 10个肝实质转移灶在两组图像上均被准确诊断,低剂量AIIR的SNR和CNR更高。

核心结论

  • 在卵巢肿瘤低剂量术前CT中,AIIR对腹膜侵犯、淋巴结转移和肝转移的诊断准确性与常规剂量腹部盆腔CT相似;使用AIIR实现最高80%的剂量缩减是可行且诊断安全的。

研究设计与样本

  • 前瞻性研究,纳入88例病理确诊卵巢肿瘤患者,先行常规剂量门静脉期CT(120 kVp/参考200 mAs)联合HIR,后行低剂量CT(120 kVp/参考40 mAs)联合AIIR,以病理结果为参考标准。

关键影像表现/征象

  • 低剂量AIIR图像上肝实质转移灶的SNR和CNR高于常规剂量HIR。
  • 低剂量AIIR对肝门、胆囊窝和段间裂等肝周结构的清晰度评分优于常规剂量HIR。

诊断标准与关键数值

  • 腹膜侵犯诊断:低剂量AIIR的AUC为0.961,常规剂量HIR的AUC为0.960(p=0.734)。
  • 淋巴结转移诊断:低剂量AIIR的AUC为0.711,常规剂量HIR的AUC为0.715(p=0.355)。
  • 肝实质转移:10个转移灶在两组图像上均被准确诊断。

临床应用与阅片要点

  • 低剂量AIIR可用于卵巢肿瘤术前分期评估腹膜侵犯、淋巴结转移和肝转移,有效剂量较常规剂量降低79.8%(2.64 ± 0.46 mSv vs. 13.04 ± 2.25 mSv,p < 0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Diagnosis of peritoneal invasion, lymph node metastasis, and hepatic metastasis is crucial in the decision-making process of ovarian tumor treatment. This study aimed to test the feasibility of low-dose abdominopelvic CT with an artificial intelligence iterative reconstruction (AIIR) for diagnosing peritoneal invasion, lymph node metastasis, and hepatic metastasis in pre-operative imaging of ovarian tumor.

METHODS: This study prospectively enrolled 88 patients with pathology-confirmed ovarian tumors, where routine-dose CT at portal venous phase (120 kVp/ref. 200 mAs) with hybrid iterative reconstruction (HIR) was followed by a low-dose scan (120 kVp/ref. 40 mAs) with AIIR. The performance of diagnosing peritoneal invasion and lymph node metastasis was assessed using receiver operating characteristic (ROC) analysis with pathological results serving as the reference. The hepatic parenchymal metastases were diagnosed and signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were measured. The perihepatic structures were also scored on the clarity of porta hepatis, gallbladder fossa and intersegmental fissure.

RESULTS: The effective dose of low-dose CT was 79.8% lower than that of routine-dose scan (2.64 ± 0.46 vs. 13.04 ± 2.25 mSv, p < 0.001). The low-dose AIIR showed similar area under the ROC curve (AUC) with routine-dose HIR for diagnosing both peritoneal invasion (0.961 vs. 0.960, p = 0.734) and lymph node metastasis (0.711 vs. 0.715, p = 0.355). The 10 hepatic parenchymal metastases were all accurately diagnosed on the two image sets. The low-dose AIIR exhibited higher SNR and CNR for hepatic parenchymal metastases and superior clarity for perihepatic structures.

CONCLUSION: In low-dose pre-operative CT of ovarian tumor, AIIR delivers similar diagnostic accuracy for peritoneal invasion, lymph node metastasis, and hepatic metastasis, as compared to routine-dose abdominopelvic CT. It is feasible and diagnostically safe to apply up to 80% dose reduction in CT imaging of ovarian tumor by using AIIR.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Cai X, Han J, Zhou W, et al. The utility of low-dose pre-operative CT of ovarian tumor with artificial intelligence iterative reconstruction for diagnosing peritoneal invasion, lymph node and hepatic metastasis. Abdom Radiol (NY). 2025. PMID: 40358704. doi:10.1007/s00261-025-04977-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。